Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China

• Main Authors: Bingyan Cao (Author), Wu Di (Author), Chang Su (Author), Jiajia Chen (Author), Xuejun Liang (Author), Min Liu (Author), Wenjing Li (Author), Xiaoqiao Li (Author), Chunxiu Gong (Author)
• Format: Book
• Published: Wiley, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACT Importance Octreotide is an off‐label medicine for congenital hyperinsulinism (CHI), but is currently widely used for treatment of patients with CHI. Thus far, variable efficacy and adverse effects have been reported for octreotide. Objective The present study evaluated the efficacy and saf...